Literature DB >> 845272

Polymorphonuclear leucocyte function in Behçet's disease.

J D Sobel, S Haim, N Obedeanu, T Meshulam, D Merzbach.   

Abstract

Polymorphonuclear leucocyte function was investigated in 19 patients with active Behçet's disease. Spontaneous free leucocyte migration was found to be significantly reduced, yet after stimulation the leucocyte's chemotactic activity was considerably increase (p less than 0-05) when compared to control leucocytes. Control leucocytes migrated more rapidly when incubated in serum taken from patients with Behçet's disease (p less than 0-005). The enhanced chemotactic activity in Bechçet's disease appears to be due to both serum and intrinsic leucocyte factors. Spontaneous nitroblue tetrazolium reduction was found to be normal, although after stimulation leucocyte nitroblue tetrazolium reduction was lower than in the control group (P less than 0-025), as was leucocyte oxygen utilisation. It is suggested that the hyperreactive cellular inflammatory response that characterises Behçet's disease may be due to increased chemotactic activity and minor alterations in functional metabolic activity of leucocytes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 845272      PMCID: PMC476367          DOI: 10.1136/jcp.30.3.250

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes.

Authors:  R D Nelson; P G Quie; R L Simmons
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

Review 2.  Behçet's disease. Report of 41 cases and a review of the literature.

Authors:  T Chajek; M Fainaru
Journal:  Medicine (Baltimore)       Date:  1975-05       Impact factor: 1.889

3.  Chemotaxis of human polymorphonuclears in vitro. II. Technical study.

Authors:  P C Frei; M H Baisero; M Ochsner
Journal:  J Immunol Methods       Date:  1974-10       Impact factor: 2.303

4.  Letter: The NBT test in Behçet's syndrome.

Authors:  K Okuda; I Tanokoro; M Sekido
Journal:  N Engl J Med       Date:  1974-04-18       Impact factor: 91.245

5.  Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes.

Authors:  J I Gallin; R A Clark; H R Kimball
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

6.  [Complement titer in patient with Behçet's disease].

Authors:  M Kogure; K Shimada; H Hara
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1971

7.  Leucocyte movement and colchicine treatment in Behcet's disease.

Authors:  N Matsumura; Y Mizushima
Journal:  Lancet       Date:  1975-10-25       Impact factor: 79.321

8.  Standardisation of the nitroblue-tetrazolium test.

Authors:  D Merzbach; N Obedeanu
Journal:  J Med Microbiol       Date:  1975-05       Impact factor: 2.472

9.  Neutrophil granulocyte function in patients with pulmonary infection.

Authors:  H R Hill; W J Warwick; J Dettloff; P G Quie
Journal:  J Pediatr       Date:  1974-01       Impact factor: 4.406

  9 in total
  13 in total

1.  Immunohistology of oral lesions from patients with recurrent oral ulcers and Behçet's syndrome.

Authors:  L W Poulter; T Lehner
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

2.  In vivo leucocyte migration in Behçet's syndrome.

Authors:  J Efthimiou; I E Addison; B V Johnson
Journal:  Ann Rheum Dis       Date:  1989-03       Impact factor: 19.103

3.  Circulating neutrophils in Behçet disease is resistant for apoptotic cell death in the remission phase of uveitis.

Authors:  Keita Fujimori; Keiko Oh-i; Masaru Takeuchi; Naoyuki Yamakawa; Takaaki Hattori; Takeshi Kezuka; Hiroshi Keino; Jun Suzuki; Hiroshi Goto; Jun-ichi Sakai; Masahiko Usui
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-10       Impact factor: 3.117

4.  Plasma exchange in the therapy of Behçet's disease.

Authors:  M B Raizman; C S Foster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

5.  Polymorphonuclear function in Behçet's syndrome.

Authors:  C Friman; P Davis
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

6.  Behcet's disease.

Authors:  R Graham-Brown
Journal:  Br Med J       Date:  1978-08-19

7.  Polymorphonuclear function in Behçet's syndrome.

Authors:  J N Fordham; P G Davies; A Kirk; H L Currey
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

8.  Behçet's syndrome and neutropenia.

Authors:  R C Leonard; R B Thompson
Journal:  Postgrad Med J       Date:  1981-07       Impact factor: 2.401

9.  Enhancement of granulocyte chemotaxis in Behcet's disease.

Authors:  D Djawari; O P Hornstein; J Schötz
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

10.  Neutrophil hyperchemotaxis in Behçet's disease: a possible role for monocytes orchestrating bacterial-induced innate immune responses.

Authors:  Fabricio Souza Neves; Solange Carrasco; Cláudia Goldenstein-Schainberg; Célio Roberto Gonçalves; Suzana Beatriz Veríssimo de Mello
Journal:  Clin Rheumatol       Date:  2009-08-25       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.